Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127926) titled 'Study of PUM2 Protein Levels in Blood Related to Sepsis Disease' on July 10.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Chifeng Municipal Hospital
Condition:
sepsis
Intervention:
Sepsis group
healthy adult group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Sepsis group; healthy adult group:150;Healthy control group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=331868
Published by HT Digital Content Services with permission from Health Daily ...